Sign inJoin waitlistJoin the waitlist

Anthony Mato

Physician · Arnot Ogden Medical Center

Credentials: · · · · · · · ·

History

Arnot Ogden Medical Center · Cayuga Medical Center at Ithaca
2023–Present

Hematology and Medical Oncology
2005–2008
Internal Medicine
2002–2005
University of Pennsylvania School of Medicine
SUNY Buffalo School of Medicine
1998–2002

Research

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
New England Journal of Medicine · 2017 · 1,525 citations
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2019 · 637 citations
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
Journal of Clinical Oncology · 2021 · 573 citations

Stephen Schuster
48 papers
Lindsey Roeker
47 papers · 27 as a fellow
CN
Chadi Nabhan
30 papers
Nicole Lamanna
29 papers
Danielle Brander
27 papers
Jakub Svoboda
27 papers
Andre Goy
24 papers
Chaitra Ujjani
24 papers · 2 as a fellow
Paul Barr
24 papers
Mazyar Shadman
23 papers
Brian Hill
22 papers
Meghan Thompson
21 papers · 18 as a resident

Clinical trials

A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Principal investigator · Withdrawn
Memorial Sloan Kettering Cancer Center
2020–2023
Clonal Evolution of B Cells in High-risk CLL After Idelalisib-rituximab
Principal investigator · Withdrawn
Abramson Cancer Center at Penn Medicine
2015
Study Examining the Combination of Revlimid (Lenalidomide)and Vidaza (Azacitidine) for Relapsed/Refractory CLL and SLL
Principal investigator · Terminated · Phase 2
Hackensack Meridian Health
2010–2011
Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy
Study chair · Terminated · Phase 2
TG Therapeutics, Inc.
2016–2021